A delivery tube assembly is provided, the delivery tube assembly including a delivery tube including a delivery tube attachment end, an open delivery tube second end opposite the delivery tube attachment end, an outer surface, and an inner surface defining a delivery tube cavity; and a dosage form including a therapeutic agent, wherein the dosage form is positioned within the delivery tube cavity. The assembly may also include an engagement mechanism positioned at the delivery tube attachment end. The assembly may also include a containment seal coupled to the delivery tube second end. The assembly may also include an inner containment seal positioned within the delivery tube cavity to seal the dosage form within the delivery tube cavity.

 
Web www.patentalert.com

< Stimulation system and method for treating a neurological disorder

< Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders

> Method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof

> Treatment of vision disorders using electrical, light, and/or sound energy

~ 00291